Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen Sells 10,300 Shares

Strata Critical Medical (NASDAQ:SRTA) CAO Amir Cohen sold 10,300 shares of the firm’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $5.79, for a total transaction of $59,637.00. Following the transaction, the chief accounting officer directly owned 191,838 shares of the company’s stock, valued at $1,110,742.02. This represents a 5.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Amir Cohen also recently made the following trade(s):

• On Friday, May 22nd, Amir Cohen sold 40,575 shares of Strata Critical Medical stock. The shares were sold at an average price of $5.91, for a total transaction of $239,798.25.

Strata Critical Medical Stock Performance

Shares of NASDAQ:SRTA traded up $0.01 during trading on Tuesday, reaching $6.14. 981,609 shares of the stock traded hands, compared to its average volume of 869,593. The firm’s 50-day moving average price is $4.82. Strata Critical Medical has a 52-week low of $3.40 and a 52-week high of $6.27. The company has a market capitalization of $531.29 million, a PE ratio of -76.75 and a beta of 2.15.

Strata Critical Medical (NASDAQ:SRTA) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $0.03 EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.07. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. The firm had revenue of $67.38 million for the quarter. Analysts predict that Strata Critical Medical will post -0.14 earnings per share for the current year.

Institutional Investors Weigh In On Strata Critical Medical

Large investors have recently added to or reduced their stakes in the stock. Granite Investment Partners LLC boosted its position in Strata Critical Medical by 77.0% in the 1st quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock valued at $76,000 after buying an additional 7,911 shares during the period. Seelaus Asset Management LLC raised its holdings in shares of Strata Critical Medical by 32.7% in the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after purchasing an additional 6,000 shares in the last quarter. Principal Financial Group Inc. bought a new stake in shares of Strata Critical Medical in the 1st quarter valued at about $537,000. Quantinno Capital Management LP raised its holdings in shares of Strata Critical Medical by 98.7% in the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after purchasing an additional 71,155 shares in the last quarter. Finally, Bank of America Corp DE raised its holdings in shares of Strata Critical Medical by 16.2% in the 1st quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock valued at $759,000 after purchasing an additional 25,379 shares in the last quarter. 47.36% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

SRTA has been the topic of several analyst reports. Craig Hallum initiated coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target on the stock. Weiss Ratings upgraded shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. Zacks Research upgraded shares of Strata Critical Medical to a “hold” rating in a report on Thursday, March 26th. Finally, B. Riley Financial assumed coverage on shares of Strata Critical Medical in a research note on Wednesday, March 25th. They set a “buy” rating and a $8.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $8.00.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.